Skip to main content
. 2013 Mar 31;45(1):55–62. doi: 10.4143/crt.2013.45.1.55

Table 2.

Response to chemotherapy according to KRAS mutation status

graphic file with name crt-45-55-i002.jpg

FOLFOX, 5-fluorouracil, leucovorin, and oxaliplatin; XELOX, capecitabine plus oxaliplain; FOLFIRI, 5-fluorouracil, leucovorin, and irinotecan; WT, wild type; MT, mutant.